CLINICAL_TRIALS
trial_result
· 2014-01-27
Clinical Trial Update: Saracatinib in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed By Surgery [Phase 2]
Summary
Phase 2 trial evaluating saracatinib in patients with unresectable stage III or stage IV melanoma; results were posted in 2014.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: National Cancer Institute (NCI) | Conditions: Recurrent Melanoma, Stage IIA Melanoma | Phase 2 | Status: COMPLETED | Results posted: 2014-01-27